Malcolm Hoenlein, Director at Keryx Biopharma, holds 110.00K shares in Keryx Biopharma (Ticker: KERX), holds 115.75K shares in Fortress Biotech (Ticker: FBIO), holds 78.03K shares in DarioHealth (Ticker: DRIO). Most recently, Malcolm Hoenlein ― shares of Keryx Biopharma on ― for an estimated value of ―.
Malcolm Hoenlein latest transaction was an Uninformative Buy of ―.
What was Malcolm Hoenlein's most profitable transaction?
Malcolm Hoenlein’s most profitable transaction was an Informative Buy of FBIO stock on November 10, 2014. The return on the trade was 101.90%.
What is Malcolm Hoenlein's role in Keryx Biopharma?
Malcolm Hoenlein's role in Keryx Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.